Corcept Therapeutics reported $130K in Ordinary Share Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
Ani Pharmaceuticals ANIP:US USD 1000 0
Ardelyx ARDX:US USD 19K 4K
Aurora Cannabis Inc ACB:CN CAD 6.76B 9.99M
Biomarin Pharmaceutical BMRN:US USD 186K 0
Canopy Growth Corp WEED:CN CAD 7.82B 216.52M
Corcept Therapeutics CORT:US USD 130K 2K
Depomed DEPO:US USD 5K 0
Esperion Therapeutics ESPR:US USD 72K 7K
Knight Therapeutics Inc GUD:CN CAD 607.76M 4.2M
Lannett LCI:US USD 43K 0
Lexicon Pharmaceuticals LXRX:US USD 189K 39K
Nektar Therapeutics NKTR:US USD 19K 0
Novartis NOVN:VX USD 890M 0
Novartis NVS:US USD 890M 0
Omeros OMER:US USD 627K 0
Pacira Pharmaceuticals PCRX:US USD 46K 0
Supernus Pharmaceuticals SUPN:US USD 54K 1000
Tg Therapeutics TGTX:US USD 145K 0
Ziopharm Oncology ZIOP:US USD 216K 0